Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of ulcerated and non-ulcerated necrobiosis lipoidica.
Hines A, Butterfield R, Boudreaux B, Bhullar P, Severson KJ, McBane RD, Davis MDP, Pittelkow MR, Mangold AR, Alavi A. Hines A, et al. Among authors: alavi a. Int J Dermatol. 2023 Jun;62(6):790-796. doi: 10.1111/ijd.16529. Epub 2022 Dec 7. Int J Dermatol. 2023. PMID: 36479693
An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum.
Haddadin OM, Ortega-Loayza AG, Marzano AV, Davis MDP, Dini V, Dissemond J, Hampton PJ, Navarini AA, Shavit E, Tada Y, Yamamoto T, Alavi AA. Haddadin OM, et al. Among authors: alavi aa. Arch Dermatol Res. 2024 Feb 24;316(3):89. doi: 10.1007/s00403-024-02829-0. Arch Dermatol Res. 2024. PMID: 38400852 No abstract available.
Monoclonal gammopathy in the setting of Pyoderma gangrenosum.
Saeidi V, Garimella V, Shaji K, Wetter DA, Davis MDP, Todd A, Dutz J, Alavi A. Saeidi V, et al. Among authors: alavi a. Arch Dermatol Res. 2024 May 25;316(6):268. doi: 10.1007/s00403-024-03098-7. Arch Dermatol Res. 2024. PMID: 38795175
Neutrophilic eccrine hidradenitis: a retrospective study.
Isaq NA, Anand N, Camilleri MJ, Mohandesi NA, Alavi A. Isaq NA, et al. Among authors: alavi a. Int J Dermatol. 2023 Sep;62(9):1142-1146. doi: 10.1111/ijd.16765. Epub 2023 Jun 23. Int J Dermatol. 2023. PMID: 37350432
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
Kirby JS, Okun MM, Alavi A, Bechara FG, Zouboulis CC, Brown K, Santos LL, Wang A, Bibeau KB, Kimball AB, Porter ML. Kirby JS, et al. Among authors: alavi a. J Am Acad Dermatol. 2024 Mar;90(3):521-529. doi: 10.1016/j.jaad.2023.10.034. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871805 Free article. Clinical Trial.
1,884 results